Call Us08045479576
Bromhexine HCL

Bromhexine HCL

2200.0 INR/Kilograms

Product Details:

  • EINECS No 210-212-8
  • Solubility Bromhexine hydrochloride is freely soluble in water and also soluble in alcohol. It dissolves easily, making it effective when administered in liquid forms such as syrups or solutions.
  • Boiling point 441.5 AdegC at 760 mmHg
  • Molecular Formula C14H20Br2N2 HCl
  • HS Code 29215990
  • Smell No Smell
  • Structural Formula Br | H2N-C6H12-CH2-C6H12-CH2-NH2 | Br
  • Click to View more
X

Bromhexine HCL Price And Quantity

  • 2200.0 INR/Kilograms
  • 25 Number

Bromhexine HCL Product Specifications

  • C14H20Br2N2 HCl
  • The appearance of Bromhexine hydrochloride can vary depending on the form and brand, but here are the typical characteristics for different formulations: 1. Tablets: Shape: Usually round or oval. Color: They can be white or off-white, depending on the manufacturer. Coating: Some tablets may have a smooth or film-coated surface to make swallowing easier. 2. Syrup: Color: Typically colorless or pale yellow. Consistency: Syrup has a viscous, thick consistency, which is typical for liquid medications. 3. Inhalation Solution: Color: Clear to light yellow or colorless. Consistency: It is a thin, liquid solution intended for nebulizer or inhaler use. 4. Injectable Form: Appearance: Clear, colorless solution in vials or ampoules. The exact color and form can vary depending on the specific brand or country of manufacture, but these are the general appearances. The medication should always be checked for any signs of contamination, such as discoloration or particles, before use.
  • 29215990
  • 99
  • 210-212-8
  • 441.5 AdegC at 760 mmHg
  • Bromhexine hydrochloride is freely soluble in water and also soluble in alcohol. It dissolves easily, making it effective when administered in liquid forms such as syrups or solutions.
  • 2 Years
  • Room Temperature
  • Br | H2N-C6H12-CH2-C6H12-CH2-NH2 | Br
  • No Smell
  • 611-75-6
  • Powder
  • Bitter
  • (2-amino-3,5-dibromo-1-cyclohexylmethyl)-N-cyclohexylmethylamine hydrochloride
  • not more than 1% by weigh
  • ~ 165-167 C (329-333 F)
  • Medicine Grade
  • 378.14 GSM (gm/2)
  • 1 to 5 micrometers
  • not exceed 20 ppm
  • Bromhexine
  • Bromhexine hydrochloride is primarily used as a mucolytic agent to treat respiratory conditions associated with excessive or thick mucus.
  • Pharmaceutical Intermediates

Bromhexine HCL Trade Information

  • INDIA
  • Days after Acceptance (DA) Cash Against Delivery (CAD) Cash Advance (CA) Letter of Credit (L/C) Letter of Credit at Sight (Sight L/C)
  • 100 Number Per Day
  • 7 Days
  • Yes
  • Free samples are available
  • DRUM OR BAG PACKING
  • Asia Australia South America Eastern Europe Western Europe Middle East Africa Central America North America
  • All India
  • WE PROVIDES ALL KIND OF CERTIFICATIONS AS YOU REQUIRED

Product Description

Bromhexine hydrochloride (Bromhexin HCL) is a synthetic drug used primarily as a mucolytic agent. It helps to reduce the thickness of mucus, making it easier for patients to cough it up and clear their airways. This makes it useful for treating various respiratory conditions where mucus production is a problem, such as:

  • Chronic bronchitis
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Other upper and lower respiratory tract infections

Mechanism of Action:

Bromhexine works by breaking down the mucus, making it less sticky and more fluid. It increases the production of a thinner, more watery mucus, which helps to clear the airways. Additionally, Bromhexine stimulates the ciliary action in the lungs, improving the movement of mucus.

Forms and Dosage:

Bromhexine is commonly available in various forms, including:

  • Tablets
  • Syrup
  • Inhalation solution
  • Injectable form (in some countries)

Dosage depends on the severity of the condition and the patient's age, so it's important to follow the prescribing doctor's instructions.

Common Side Effects:

While Bromhexine is generally well-tolerated, it can cause side effects, including:

  • Gastrointestinal issues (such as nausea, stomach pain, or indigestion)
  • Dizziness
  • Headache
  • Skin rash (in rare cases)

Precautions:

  • Bromhexine should be used cautiously in patients with a history of gastrointestinal problems or those with severe liver or kidney disease.
  • It is generally not recommended for use in children under 2 years old.

Always consult a doctor or healthcare provider before using Bromhexine, particularly if you're pregnant, breastfeeding, or taking other medications.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category